Natural Health Trends Reports Third Quarter 2023 Financial Results

In this article:
Natural Health Trends Corp.Natural Health Trends Corp.
Natural Health Trends Corp.
  • Total orders taken were roughly flat despite continued headwinds of a stronger dollar and trepid consumer sentiment

  • Cash flows from operations improved $1.4 million

  • Declared a quarterly cash dividend of $0.20 per share

HONG KONG, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the quarter ended September 30, 2023.

Third Quarter 2023 Financial Highlights

  • Revenue of $10.6 million decreased 9% compared to $11.7 million in the third quarter of 2022. The decrease in revenue was primarily due to the changes in deferred revenue in the two respective quarters. Deferred revenue decreased $603,000 and $1.4 million during the third quarter of 2023 and 2022, respectively, resulting in an $835,000 unfavorable revenue variance.

  • Operating loss was $292,000 compared to $145,000 in the third quarter of 2022.

  • Net income was $172,000, or $0.02 per diluted share, compared to $47,000, or breakeven per diluted share, in the third quarter of 2022.

  • The number of Active Members1 was down 6% to 34,660 at September 30, 2023 compared to 36,730 at June 30, 2023, and decreased 16% compared to 41,170 at September 30, 2022.

1 Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period.

Year-to-Date 2023 Financial Highlights

  • Revenue of $33.0 million decreased 10% compared to $36.6 million in the first nine months of 2022. The revenue decrease was primarily due to the changes in deferred revenue in the two respective nine-month periods. Deferred revenue increased $651,000 during the first nine months of 2023, but decreased $3.3 million during the same period last year, resulting in a $3.9 million unfavorable revenue variance.

  • Operating loss was $1.4 million compared to $313,000 in the first nine months of 2022.

  • Net income was $210,000, or $0.02 per diluted share, compared to $125,000, or $0.01 per diluted share, in the first nine months of 2022.

Management Commentary

“Adapting to the current environment in which Chinese consumers are reluctant to spend or invest, we managed to generate orders on pace with those of last year. Orders grew 3% at a constant exchange rate compared to the third quarter of 2022, while year-to-date 2023 orders increased 8% compared to prior year. The reported decrease in revenue was largely due to changes in deferred revenue, partly because orders tended to be received later in the quarter this year. Importantly, our members remained responsive to our programs, demonstrating that our promotions, incentives and high-quality product offerings continue to resonate,” commented Chris Sharng, President of Natural Health Trends Corp.

Mr. Sharng continued, “Noteworthy to highlight are the signs of momentum extending to several of our other markets including Taiwan, Peru, North America and Japan, each of which delivered strong performance during the quarter. We’re hopeful that these signs of growth will continue supported by careful planning and execution to our strategies around digital enhancements, new product launches, geographic diversification and superior member support.”

Balance Sheet and Cash Flow

  • Net cash used in operating activities was $4.2 million in the first nine months of 2023 compared to $5.8 million in the first nine months of 2022. Before tax installment payments, the liability of which arises from the 2017 U.S. Tax Cuts and Jobs Act (the “Act Act”), cash used in operating activities was $1.2 million in the first nine months 2023, versus $4.2 million in the comparable period a year ago. Of the total Tax Act liability of $20.2 million, $11.2 million has been paid to date.

  • Total cash and cash equivalents were $58.4 million at September 30, 2023, down from $61.6 million at June 30, 2023.

  • On October 30, 2023, the Company’s Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on November 24, 2023 to stockholders of record as of November 14, 2023.

Third Quarter 2023 Financial Results Conference Call

Management will host a conference call to discuss the third quarter 2023 financial results today, Wednesday, November 1, 2023 at 11:30 a.m. Eastern Time. The conference call details are as follows:

Date:

Wednesday, November 1, 2023

Time:

11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time

Dial-in:

1-877-407-0789 (Domestic)
1-201-689-8562 (International)

Conference ID:

13740859

Webcast:

https://viavid.webcasts.com/starthere.jsp?ei=1631150&tp_key=ea6cd96ef7

 

 

For those unable to participate during the live broadcast, a replay of the call will also be available from 2:30 p.m. Eastern Time on November 1, 2023 through 11:59 p.m. Eastern Time on November 8, 2023 by dialing 1-844-512-2921 (domestic) and 1-412-317-6671 (international) and referencing the replay pin number: 13740859.

About Natural Health Trends Corp.

Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.

Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on March 3, 2023 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

CONTACT:

Scott Davidson
Senior Vice President and Chief Financial Officer
Natural Health Trends Corp.
Tel (Hong Kong): +852-3107-0800
Tel (U.S.): 310-541-0888
investor.relations@nhtglobal.com

NATURAL HEALTH TRENDS CORP.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)

 

 

September 30, 2023

 

 

December 31, 2022

 

 

 

(Unaudited)

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

58,412

 

 

$

69,667

 

Inventories

 

 

4,882

 

 

 

4,525

 

Other current assets

 

 

3,675

 

 

 

3,359

 

Total current assets

 

 

66,969

 

 

 

77,551

 

Property and equipment, net

 

 

284

 

 

 

394

 

Operating lease right-of-use assets

 

 

3,549

 

 

 

3,992

 

Restricted cash

 

 

37

 

 

 

79

 

Deferred tax asset

 

 

303

 

 

 

195

 

Other assets

 

 

679

 

 

 

606

 

Total assets

 

$

71,821

 

 

$

82,817

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

666

 

 

$

810

 

Income taxes payable

 

 

4,092

 

 

 

2,972

 

Accrued commissions

 

 

2,589

 

 

 

2,943

 

Other accrued expenses

 

 

1,100

 

 

 

1,181

 

Deferred revenue

 

 

6,248

 

 

 

5,597

 

Amounts held in eWallets

 

 

4,154

 

 

 

4,895

 

Operating lease liabilities

 

 

1,182

 

 

 

1,135

 

Other current liabilities

 

 

747

 

 

 

905

 

Total current liabilities

 

 

20,778

 

 

 

20,438

 

Income taxes payable

 

 

5,054

 

 

 

9,098

 

Deferred tax liability

 

 

140

 

 

 

141

 

Operating lease liabilities

 

 

2,539

 

 

 

2,989

 

Total liabilities

 

 

28,511

 

 

 

32,666

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Preferred stock

 

 

 

 

 

 

Common stock

 

 

13

 

 

 

13

 

Additional paid-in capital

 

 

84,657

 

 

 

86,102

 

Accumulated deficit

 

 

(15,757

)

 

 

(9,056

)

Accumulated other comprehensive loss

 

 

(1,267

)

 

 

(1,004

)

Treasury stock, at cost

 

 

(24,336

)

 

 

(25,904

)

Total stockholders’ equity

 

 

43,310

 

 

 

50,151

 

Total liabilities and stockholders’ equity

 

$

71,821

 

 

$

82,817

 

 

 

 

 

 

 

 

 

 

NATURAL HEALTH TRENDS CORP. 
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In thousands, except per share data)

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Net sales

 

$

10,615

 

 

$

11,716

 

 

$

32,987

 

 

$

36,622

 

Cost of sales

 

 

2,689

 

 

 

3,098

 

 

 

8,386

 

 

 

9,398

 

Gross profit

 

 

7,926

 

 

 

8,618

 

 

 

24,601

 

 

 

27,224

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commissions expense

 

 

4,361

 

 

 

4,863

 

 

 

13,861

 

 

 

15,370

 

Selling, general and administrative expenses

 

 

3,857

 

 

 

3,900

 

 

 

12,169

 

 

 

12,167

 

Total operating expenses

 

 

8,218

 

 

 

8,763

 

 

 

26,030

 

 

 

27,537

 

Loss from operations

 

 

(292

)

 

 

(145

)

 

 

(1,429

)

 

 

(313

)

Other income, net

 

 

585

 

 

 

187

 

 

 

1,708

 

 

 

472

 

Income before income taxes

 

 

293

 

 

 

42

 

 

 

279

 

 

 

159

 

Income tax provision (benefit)

 

 

121

 

 

 

(5

)

 

 

69

 

 

 

34

 

Net income

 

$

172

 

 

$

47

 

 

$

210

 

 

$

125

 

Net income per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.02

 

 

$

0.00

 

 

$

0.02

 

 

$

0.01

 

Diluted

 

$

0.02

 

 

$

0.00

 

 

$

0.02

 

 

$

0.01

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

11,440

 

 

 

11,423

 

 

 

11,432

 

 

 

11,341

 

Diluted

 

 

11,454

 

 

 

11,423

 

 

 

11,449

 

 

 

11,423

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NATURAL HEALTH TRENDS CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)

 

 

Nine Months Ended September 30,

 

 

 

2023

 

 

2022

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

Net income

 

$

210

 

 

$

125

 

Adjustments to reconcile net income to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

130

 

 

 

156

 

Share-based compensation

 

 

123

 

 

 

 

Noncash lease expense

 

 

830

 

 

 

889

 

Deferred income taxes

 

 

(117

)

 

 

(2

)

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

Inventories

 

 

(420

)

 

 

140

 

Other current assets

 

 

(425

)

 

 

1,000

 

Other assets

 

 

(92

)

 

 

(44

)

Accounts payable

 

 

(141

)

 

 

228

 

Income taxes payable

 

 

(2,923

)

 

 

(1,382

)

Accrued commissions

 

 

(315

)

 

 

(1,055

)

Other accrued expenses

 

 

(58

)

 

 

(540

)

Deferred revenue

 

 

674

 

 

 

(3,209

)

Amounts held in eWallets

 

 

(725

)

 

 

(1,150

)

Operating lease liabilities

 

 

(812

)

 

 

(950

)

Other current liabilities

 

 

(148

)

 

 

4

 

Net cash used in operating activities

 

 

(4,209

)

 

 

(5,790

)

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

Purchases of property and equipment

 

 

(32

)

 

 

(130

)

Net cash used in investing activities

 

 

(32

)

 

 

(130

)

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

Dividends paid

 

 

(6,911

)

 

 

(6,855

)

Net cash used in financing activities

 

 

(6,911

)

 

 

(6,855

)

Effect of exchange rates on cash, cash equivalents and restricted cash

 

 

(145

)

 

 

(858

)

Net decrease in cash, cash equivalents and restricted cash

 

 

(11,297

)

 

 

(13,633

)

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period

 

 

69,746

 

 

 

84,365

 

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period

 

$

58,449

 

 

$

70,732

 

SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

Right-of-use assets obtained in exchange for operating lease liabilities

 

$

115

 

 

$

2,218

 

 

 

 

 

 

 

 

 

 


Advertisement